If you wonder why Small Cap Network members have been providing thorough footage on AtheroNova Inc. (OTC:AHRO) for the last couple of days, it is simply because they got paid $20 thousand to raise awareness about AHRO stock.
The latter lost 4.5% in value yesterday when it closed the session at $1.50 on a volume of 8,400, which is slightly higher than the average daily trading volume of 6,600. Thus, AHRO stock registered a second negative trading session after soaring by a staggering 34% last Thursday.
As far as the possible impact of the current promotion is concerned, it will most likely provide investors with some favourable opportunities to get out at a profit if they act quick enough. As it seems, however, the promoter started flooding investors’ emails with AHRO alerts a couple of days prior to announcing the actual size of the compensation package.
Following an almost four-week period of silence, AHRO finally issued a fresh press release on its current activities yesterday. According to the update, the results of a company-sponsored research revealed that the use of its AHRO-001 as dietary supplementation helped reduce the formation of arterial plaque by 95%. Surprisingly or not, traders did not seem to care about the update, hence AHRO’s sub-par market run yesterday.
Considering that a positive update could not give AHRO stock a boost, what will happen later today will be indicative of whether AHRO will succumb to promotional pressure or resist doing so. Either way, the company still has a long way to go before reaching a milestone.
